Ignite Creation Date:
2024-05-06 @ 6:56 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05837052
Status:
RECRUITING
Last Update Posted:
2023-07-17
First Post:
2023-04-17
Brief Title:
A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC
Sponsor:
Organization:
Zhejiang University